Clinical Trial Update: A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

View source ↗

Summary

Clinical study evaluating the combination of sorafenib and gefitinib for pancreatic neuroendocrine neoplasm is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Neoplasm

Drugs mentioned

• Iressa (gefitinib)
• Nexavar (Sorafenib)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Pancreatic Neuroendocrine Neoplasm, Sorafenib | Status: RECRUITING